bevacizumab,trifluridine tipiracil
taiho pharma,roche,otsuka
[]
#gi23 #ascogi23 phase iii sunlight trial of lonsurf +/- bev os by 3.3m validating prior phase ii data #cancer #cancerresearch #clinicaltrials #crcsm 
Co-Director/Co-Leader GI Oncology Research; Director, Young Adult Cancers Program; Co-Chair, NCI GI Steering Committee; and Director for Strategic Relations